tributyrin for cognitive dysfunction

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Jan 2025: Trial registered, NCT06797817

The trials

NCT06797817: Tributyrin Treatment in Mild Alzheimer Disease: Assessment of Butyrate Effects Via the Gut-Brain

State
Not started
Phase
Phase 3
People
156 planned
Started
1 Jun 2026
Primary completion
1 Sep 2026
Arms
Tributyrin
Results
None posted
  1. 28 Jan 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Diet or lifestyle.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.